Abstract session: NAFLD - Experimental

 Metabolism, alcohol and toxicity

Room 3
English
Abstract session
29 August 2020 11:00 - 12:30


Presentations

Title Time

Add to Calendar

AS133 Myosteatosis is associated with early NASH in the context of obesity and metabolic syndrome
29 August 2020 11:00 - 11:15
AS134 Vitamin D3 up-regulated protein 1 attenuates nonalcoholic steatohepatitis by regulating AMPK/mTORC1/TFEB-mediated autophagy.
29 August 2020 11:15 - 11:30
AS135 Inhibition of ∆24-dehydrocholesterol reductase ameliorates non-alcoholic steatohepatitis in mice
29 August 2020 11:30 - 11:45
AS136 The bile acid derivative norursodeoxycholic acid affects fatty-liver associated anhedonia and anxiety in mice
29 August 2020 11:45 - 12:00
AS137 Effect of the hepatic extracellular vesicles in inflammation-associated insulin resistance in non-alcoholic fatty liver disease
29 August 2020 12:00 - 12:15
AS138 Alterations in bile acids and TGR5 activation in nonalcoholic steatohepatitis
29 August 2020 12:15 - 12:30